We are the
Drug Safety Research Unit
The UK’s leading pharmacovigilance and pharmacoepidemiology service provider.
Pharmacovigilance & Pharmacoepidemiology Services
Engage the DSRU to meet your pharmacovigilance and pharmacoepidemiology requirements.
Consulting at DSRU
Expertise in pharmacovigilance, pharmacoepidemiology & risk management.
Education & Training
Make yourself a prime candidate for the role you aspire to by studying with DSRU.
The DSRU is an independent unit internationally respected for its work in Pharmacovigilance, Pharmacoepidemiology, Risk Management, Risk Minimisation for over 40 years.
The Unit conducts a broad range of pharmacoepidemiological studies using a variety of study methods and data sources. The DSRU conducts safety and drug utilisation studies and studies to support risk management and risk minimisation. In addition, the DSRU conducts studies and systematic reviews to understand the safety, use and risk-benefit balance of medicines and vaccines using real world data.
The DSRU is also a leading provider of education and training in pharmacovigilance and pharmacoepidemiology. The Drug Safety Research Unit (DSRU), led by Director Linda Härmark, aims to protect patients from undesirable adverse effects of medicines in clinical use.
Linda Härmark
Director
News & press
Latest news & press releases from DSRU
DSRU looks forward to ISPE conference!
The DSRU team is off to Milan on 30th August for the 42nd Annual Meeting of the International Society for...
Shaping Vaccine Safety Evidence Across Europe
DSRU colleagues have contributed to a major VAC4EU study examining thrombosis with thrombocytopaenia syndrome (TTS) — a rare blood clotting...
DSRU attends ISoP Mid-Year Meeting
Some of the DSRU’s pharmacovigilance experts attended the mid year meeting of the International Society of Pharmacovigilance (ISoP) in Hatfield,...
DSRU/ PIPA Webinar: Additional Risk Minimisation Measures
The DSRU physicians, Dr Miranda Davies and Dr Sandeep Dhanda, were delighted to present a webinar to members of the...
Causality Assessment Tools: Scoping Review Published
The International Working Group (IWG) on New Developments in Pharmacovigilance has conducted a scoping review of Causality Assessment Tools (CATs)...
DSRU Co-Hosts VAC4EU General Assembly in Southampton
The Drug Safety Research Unit (DSRU) is proud to co-host the 13th General Assembly Meeting of the Vaccine monitoring Collaboration...Testimonials
What our stakeholders are saying about us
Aims to protect patients from undesirable adverse effects of medicines in clinical use
I am very satisfied with the work and involvement that DSRU personnel has in the ***** studies. DSRU are very well known and highly regarded in the pharmaceutical industry. The support they have given to ***** is of the highest possible quality. DSRU have the best professionals for data analysis from epi studies and they have proven it again with the ***** project. The quality of work is impeccable.
A pleasure to work with
Highly collaborative and highly ethical, and a pleasure to work with.